[HTML][HTML] Plasma proteins predict conversion to dementia from prodromal disease
A Hye, J Riddoch-Contreras, AL Baird, NJ Ashton… - Alzheimer's & …, 2014 - Elsevier
Background The study aimed to validate previously discovered plasma biomarkers associated
with AD, using a design based on imaging measures as surrogate for disease severity …
with AD, using a design based on imaging measures as surrogate for disease severity …
[HTML][HTML] Blood-based proteomic biomarkers of Alzheimer's disease pathology
AL Baird, S Westwood, S Lovestone - Frontiers in neurology, 2015 - frontiersin.org
The complexity of Alzheimer’s disease (AD) and its long prodromal phase poses challenges
for early diagnosis and yet allows for the possibility of the development of disease modifying …
for early diagnosis and yet allows for the possibility of the development of disease modifying …
The staircase test of skilled reaching in mice
AL Baird, A Meldrum, SB Dunnett - Brain research bulletin, 2001 - Elsevier
The “staircase” test has become established for measurement of side-specific deficits in
coordinated paw reaching in rats, and has been shown to reveal impairments on the …
coordinated paw reaching in rats, and has been shown to reveal impairments on the …
[HTML][HTML] A decade of blood biomarkers for Alzheimer's disease research: an evolving field, improving study designs, and the challenge of replication
L Shi, AL Baird, S Westwood, A Hye… - Journal of …, 2018 - content.iospress.com
Blood-based biomarkers represent a less invasive and potentially cheaper approach for
aiding Alzheimer’s disease (AD) detection compared with cerebrospinal fluid and some …
aiding Alzheimer’s disease (AD) detection compared with cerebrospinal fluid and some …
Circadian rhythms and attention deficit hyperactivity disorder: The what, the when and the why
Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental condition
characterised by impulsivity, inattention and hyperactivity. Aside from these core …
characterised by impulsivity, inattention and hyperactivity. Aside from these core …
[HTML][HTML] MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study
…, AL Baird, C Legido-Quigley, L Bertram… - Alzheimer's research & …, 2018 - Springer
Background With the shift of research focus towards the pre-dementia stage of Alzheimer’s
disease (AD), there is an urgent need for reliable, non-invasive biomarkers to predict amyloid …
disease (AD), there is an urgent need for reliable, non-invasive biomarkers to predict amyloid …
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
L Shi, S Westwood, AL Baird… - Alzheimer's & …, 2019 - Wiley Online Library
Introduction Plasma proteins have been widely studied as candidate biomarkers to predict
brain amyloid deposition to increase recruitment efficiency in secondary prevention clinical …
brain amyloid deposition to increase recruitment efficiency in secondary prevention clinical …
[HTML][HTML] Blood protein predictors of brain amyloid for enrichment in clinical trials?
Background Measures of neocortical amyloid burden (NAB) identify individuals who are at
substantially greater risk of developing Alzheimer's disease (AD). Blood-based biomarkers …
substantially greater risk of developing Alzheimer's disease (AD). Blood-based biomarkers …
Blood-based biomarker candidates of cerebral amyloid using PiB PET in non-demented elderly
Increasingly, clinical trials for Alzheimer’s disease (AD) are being conducted earlier in the
disease phase and with biomarker confirmation using in vivo amyloid PET imaging or CSF tau …
disease phase and with biomarker confirmation using in vivo amyloid PET imaging or CSF tau …
[HTML][HTML] The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer's pathology
S Westwood, B Liu, AL Baird, S Anand… - Alzheimer's Research & …, 2017 - Springer
Background Insulin resistance (IR) has previously been associated with an increased risk of
developing Alzheimer’s disease (AD), although the relationship between IR and AD is not …
developing Alzheimer’s disease (AD), although the relationship between IR and AD is not …